Mergers and Acquisitions

New On The Block Abry Partners hired JPMorgan Chase to find a buyer for physician social network Sermo, Axios reports. Bids are expected to be between $600 million and $800 million. Boston-based Abry first invested in Sermo in 2019. Verint Systems Inc. (NASDAQ:VRNT), a provider of call center...

New On The Block Bahama Breeze may soon be gone with the wind. Darden Restaurants (NYSE:DRI) is considering selling the Caribbean-inspired chain or repurposing all its locations. The decision comes after Darden closed 15 Bahama Breeze restaurants in May, leaving just 28. Guru Focus reported that...

New On The Block Spanish La Liga club Getafe is considering a sale, per The Telegraph. On the buyside is Fenway Sports Group (FSG), the Boston-based firm led by billionaire John W. Henry. FSG already owns Liverpool FC, the Boston Red Sox and Pittsburgh Penguins. Ángel Torres, Getafe's current...

U.S. Steel Corp. (NYSE:X) shares rallied Monday after President Donald Trump approved the company’s takeover by Japan's Nippon Steel. The deal faced opposition and multiple reviews. It’s now clear to close after both firms committed to a series of measures designed to protect U.S....

New On The Block Bankers say these biscuits are worth billions. The $1.5 billion asking price for Bojangles, the fried chicken and biscuit fast-food chain, is about triple what private equity firms Durational Capital Management and TJC paid in 2019—just four years after the chain went public....

BioNTech SE (NASDAQ:BNTX) on Thursday agreed to acquire CureVac N.V. (NASDAQ:CVAC) in an all-stock transaction. According to the agreement, shareholders can exchange CureVac shares for around $5.46 in BioNTech ADSs. This equates, roughly, to an equity value of $1.25 billion. The consideration...

New On The Block Byron Allen's Allen Media Group has hired Moelis & Company to explore a sale of its TV stations across 21 markets. The company spent over $1 billion acquiring Big Four network affiliates (ABC, NBC, CBS, FOX) over the past six years. It is now looking to cash out and reduce...

Thoma Bravo has raised $34.4 billion across three funds, marking one of the largest fundraising hauls in recent private equity history. What Happened: According to the Wall Street Journal, the investment giant secured $24.3 billion for its flagship buyout fund. The effort matches its 2022 total and...

Canned soup products maker The Campbell's Company (NASDAQ:CPB) shares are trading higher in the premarket on Monday. The company reported third-quarter sales growth of 4% year over year (Y/Y) to $2.475 billion, beating the analyst consensus estimate of...

New On The Block Revolution Beauty is putting itself in the shop window. The UK cosmetics brand has kicked off a formal sale process and is considering funding options as part of a broader strategic review, including a potential sale. Advisors are on board and talks with interested parties have...

Energy company EOG Resources, Inc. (NYSE:EOG) shares are trading lower premarket on Friday. The firm inked a deal to acquire Encino Acquisition Partners (EAP) for $5.6 billion, including EAP’s net debt. EOG agreed to pay the sellers, Canada Pension Plan Investment Board (CPP) and Encino...

NSFW content platform OnlyFans is seeking a tantalizing $8 billion price tag. Leonid Radvinsky‘s Fenix International, the UK-based parent company, is chatting with a consortium led by U.S. investment firm Forest Road Company. The group includes Disney and TikTok alum Kevin Mayer, because...

Telsey Advisory Group analyst Cristina Fernández reiterated the Market Perform rating on Foot Locker, Inc. (NYSE:FL) on Friday, raising the price forecast from $20 to $24. Foot Locker shares rocketed premarket on Thursday after the company disclosed a definitive deal to be acquired by ...

New On The Block Starbucks (NASDAQ:SBUX) is brewing up some big decisions for its China business, including a potential stake deal that could fetch several billion dollars. The coffee giant has been quietly chatting with tech firms and private equity players, hoping someone might want a sip of its...

GSK plc (NYSE:GSK) on Wednesday agreed to acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa. Under the agreement, GSK will pay up to $2 billion in total cash consideration. This includes $1.2 billion upfront, with the potential for additional success-based milestone payments...